Spared Motivational Modulation of Cognitive Effort in a Maternal Immune Activation Model of Schizophrenia Risk

被引:15
|
作者
Bates, Vanessa [1 ]
Maharjan, Ashim [1 ]
Millar, Jessica [1 ]
Bilkey, David K. [1 ]
Ward, Ryan D. [1 ]
机构
[1] Univ Otago, Dept Psychol, POB 56, Dunedin 9054, New Zealand
关键词
maternal immune activation; signaled reward probability; motivation; schizophrenia; poly I:C; NEURODEVELOPMENTAL ANIMAL-MODEL; NEGATIVE SYMPTOMS; DOPAMINERGIC HYPERFUNCTION; REWARD PROBABILITY; RAT MODEL; DEFICITS; INHIBITION; ETIOLOGY; IMPACT; MICE;
D O I
10.1037/bne0000230
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Maternal immune activation (MIA) during gestation is a significant risk factor for development of schizophrenia and other neurodevelopmental diseases. In animal models of this risk factor, MIA during pregnancy can produce offspring that recapitulate certain aspects of the behavioral and neurophysiological impairments seen in schizophrenia. Here, the authors tested the effect of polyinosinic-polycytidylic acid (poly I:C)-induced MIA in a task that explicitly assays the interaction between motivation and cognition. In our paradigm, discrimination accuracy during a sustained-attention task is differentially impacted by environmental cues that signal the probability of reward for accurate performance. Cognition-motivation interactions are implicated in producing functional impairments in patients. Therefore, to the extent that this MIA model recapitulates such impairments, the authors predicted impaired ability of reward-associated signals to modulate cognitive performance in MIA rat offpsring. Adult offspring of dams in which MIA was induced displayed impaired prepulse inhibition relative to controls, verifying a functional effect of poly I: C induction. Despite this deficit, there were no differences between MIA and control rats in any aspects of task learning or performance, including under extinction and reacquisition conditions. These results indicate that MIA spares functioning of some of the cognitive, motivational, and decision-making processes that are impacted in schizophrenia and suggest that MIA as an isolated manipulation does not model the full range and nuance of the cognitive and motivational impairments in the disease. The authors suggest that some aspects of the functional impairment in schizophrenia and other neurodevelopmental diseases may be better modeled using multiple "hit" models of disease risk.
引用
收藏
页码:66 / 74
页数:9
相关论文
共 50 条
  • [21] Using a maternal immune stimulation model of schizophrenia to study behavioral and neurobiological alterations over the developmental course
    Hadar, Ravit
    Luisa Soto-Montenegro, Ma
    Goetz, Thomas
    Wieske, Franziska
    Sohr, Reinhard
    Desco, Manuel
    Hamani, Clement
    Weiner, Ina
    Pascau, Javier
    Winter, Christine
    SCHIZOPHRENIA RESEARCH, 2015, 166 (1-3) : 238 - 247
  • [22] JNK signalling mediates aspects of maternal immune activation: importance of maternal genotype in relation to schizophrenia risk
    Openshaw, Rebecca L.
    Kwon, Jaedeok
    McColl, Alison
    Penninger, Josef M.
    Cavanagh, Jonathan
    Pratt, Judith A.
    Morris, Brian J.
    JOURNAL OF NEUROINFLAMMATION, 2019, 16 (1)
  • [23] JNK signalling mediates aspects of maternal immune activation: importance of maternal genotype in relation to schizophrenia risk
    Rebecca L. Openshaw
    Jaedeok Kwon
    Alison McColl
    Josef M. Penninger
    Jonathan Cavanagh
    Judith A. Pratt
    Brian J. Morris
    Journal of Neuroinflammation, 16
  • [24] Maternal Immune Activation by Poly I:C as a preclinical Model for Neurodevelopmental Disorders: A focus on Autism and Schizophrenia
    Haddad, Faraj L.
    Patel, Salonee, V
    Schmid, Susanne
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2020, 113 : 546 - 567
  • [25] The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia
    De Felice, Marta
    Melis, Miriam
    Aroni, Sonia
    Muntoni, Anna Lisa
    Fanni, Silvia
    Frau, Roberto
    Devoto, Paola
    Pistis, Marco
    CNS NEUROSCIENCE & THERAPEUTICS, 2019, 25 (05) : 549 - 561
  • [26] Maternal Immune Activation and Schizophrenia-Evidence for an Immune Priming Disorder
    Choudhury, Zahra
    Lennox, Belinda
    FRONTIERS IN PSYCHIATRY, 2021, 12
  • [27] The PPARα agonist fenofibrate reduces the cytokine imbalance in a maternal immune activation model of schizophrenia
    Mostallino, Rafaela
    Santoni, Michele
    Sagheddu, Claudia
    Serra, Valentina
    Orru, Valeria
    Pistis, Marco
    Castelli, M. Paola
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 961
  • [28] Adolescent olanzapine sensitization is correlated with hippocampal stem cell proliferation in a maternal immune activation rat model of schizophrenia
    Chou, Shinnyi
    Jones, Sean
    Li, Ming
    BRAIN RESEARCH, 2015, 1618 : 122 - 135
  • [29] The maternal immune activation (MIA) model of schizophrenia produces pre-pulse inhibition (PPI) deficits in both juvenile and adult rats but these effects are not associated with maternal weight loss
    Wolff, Amy. R.
    Bilkey, David. K.
    BEHAVIOURAL BRAIN RESEARCH, 2010, 213 (02) : 323 - 327
  • [30] Imaging extra-striatal dopamine D2 receptors in a maternal immune activation rat model
    Oh-Nishi, Arata
    Nagai, Yuji
    Seki, Chie
    Suhara, Tetsuya
    Minamimoto, Takafumi
    Higuchi, Makoto
    BRAIN, BEHAVIOR, & IMMUNITY - HEALTH, 2022, 22